On September 22nd  the federal government announced the statutory review of the Cannabis Act had begun. What this means for medical: There are a list of questions brought up in their paper. Most notable is the following: Is a distinct medical access program necessary to provide individuals with reasonable access to cannabis for medical purposes, or can access needs be…

CFAMM/MCC Founder Jonathan Zaid joins alongside Ashleigh Brown, Alexander Repetski and Mika Unterman Medical Cannabis Canada (MCC) / Cannabis Médical Canada (CMC) is excited to announce the addition of four new members to its board of directors. Jonathan Zaid, MCC (formerly CFAMM) founder will be joining as our new Vice-Chairperson, alongside other new board members…

Gerald Major has stepped down from the Board of Directors after over 6 years with the organization, and we thank him for his tireless work as a patient and advocate helping to advance positive outcomes for medical cannabis in Canada.  Board Member, Max Monahan-Ellison, will be taking over as Chair of the Board of Directors.…

On December 11th, Health Canada announced they are seeking consultation from Canadians on cannabis regulations, specifically cannabis research and other regulatory issues. You can read the full Notice of Intent here, and you can get involved!  About this consultation:  Health Canada is looking for feedback on its intent to amend the Cannabis Regulations (CR) and…

Thank you to the speakers, organizers, and sponsors of the Real World Medicannabis Symposium! In case you missed it, the focus of the symposium was on the importance and application of Real World Evidence for promoting the safety and efficacy of medical cannabis use. Clinic trials aren’t enough. Randomized clinical trials (RCTs) are the gold…